Clinical TrialID 139

Mucuna Pruriens Therapy in Parkinson's Disease

NCT02680977

Parkinson's Disease

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
139
Evidence Id
139
Core Evidence Id
139
Source Clinical Trial Id
134
Herb2 Clinical Trial Id
HBCT000134
Nct Id
NCT02680977
Title
Mucuna Pruriens Therapy in Parkinson's Disease
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Parkinson's Disease
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
OTHER: MP-Equivalent|OTHER: MP-Low|OTHER: MP+DDCI|DRUG: LD+DDCI|DRUG: LD-DDCI|OTHER: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
18
Outcome Measure
Magnitude of motor response, Percentage of change in UPDRS motor score (part III) from baseline (overnight OFF state) to 90 minutes and 180 minutes after acute intake (full ON state), up to 3 hours
Sponsor Collaborator
ASST Gaetano Pini-CTO|Grisons Foundation for Parkinson's Disease
Funded By
OTHER
Location
Clinica Niño Jesus, Santa Cruz de la Sierra, Bolivia
Other Id
SBN.SC.013/2015
Start Date
2016-02
Primary Completion Date
2016-05
Completion Date
2016-09
First Posted
2016-02-12
Results First Posted
Last Update Posted
2016-10-05
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02680977
Title Cn
Title En
Mucuna Pruriens Therapy in Parkinson's Disease
Bilingual Status
semi_complete